MedTrace Logo

Clinical Evaluation of White Spot Lesions Treated by S-PRG and ICON

NCT05550116 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-09-26

No results posted yet for this study

Summary

Randomized with (1:1) prospective, double-blind, controlled trial. Subjects will be randomized to receive S-PRG and the control group receives ICON.

Conditions

  • White Spot Lesion

Interventions

OTHER

Giomer

fluoride-releasing coating material containing surface reaction-type pre-reacted glass-ionomer (S-PRG) fillers

OTHER

Two composite resin sealants

Unfilled composite resin sealants

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Khalid Noman, PROF · Alazhar Univerisity

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-11
Primary Completion
2022-08-30
Completion
2022-10-11

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05550116 on ClinicalTrials.gov